Evidence map›Paper›PMID 41629328›Full record

ArticleNature communications2026

Counteracting FOX proteins epigenetically control the herpesvirus lytic-latent balance.

Yuhang Xiang, Xiyuan Yang, Juncheng Zhang, Fujun Hou, Yue Deng, Hui Fu, Hyung Suk Oh, Qiongyan Wang, Siyu Chen, Zeyu Sun and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Yuhang XiangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xiyuan YangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Juncheng ZhangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Fujun HouState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yue DengState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Hui FuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Hyung Suk OhDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-1739-0389
Qiongyan WangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Siyu ChenState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zeyu SunState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID 0000-0003-0218-2277
Biswajit DasDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-2888-8665
Yao Yu YeoCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0002-7604-2296
Jean M PesolaDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
Pritha SenTransplant, Oncology, and Immunocompromised Host Group, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA.
Sizun JiangCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID 0000-0001-6149-3142
David M KnipeDepartment of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-1554-6236
Donald M CoenDepartment of Biological Chemistry and Molecular Pharmacology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-2148-5671
Dongli PanState Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. pandongli@zju.edu.cn.ORCID 0000-0002-0421-6242

Funding

NHP CoreP01AI177687 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI Dan H. Barouch · 2023 to 2026
$7.4M
American Heart Association (American Heart Association, Inc.) Career Development AwardNational Natural Science Foundation of China (National Science Foundation of China) 82272322U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 5P01AI098681U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) P01AI177687
6 · The paper itself

Abstract

The lytic-latent balance is a major viral persistence strategy and obstacle to curing viral diseases, yet its mechanisms remain poorly understood. Following lytic infection in non-neuronal cells, herpes simplex virus (HSV) establishes latency specifically in neurons and is reactivated by stresses. Here we identify forkhead box (FOX) transcription factors that can strongly activate or repress replication of HSV-1 and other alphaherpesviruses, and show that neurons express activating Fox (e.g., Foxf) genes poorly but repressive Fox (Foxk) genes abundantly while non-neuronal or stressed neuronal cells exhibit higher expression of activating Fox genes. Remarkably, knockdown of Foxk1 or overexpression of activating Fox genes induces reactivation from latency in male mouse neuronal culture and in vivo. Of note, FOX proteins bind the viral genome globally and nonsequence-specifically and interact with epigenetic cofactors for gene regulation. FOXF1 interacts with CBP and P300 to acetylate and open viral chromatin. FOXK1 works with SIN3A, a cofactor of histone deacetylation, and MAX to suppress HSV-1 and antagonize activating FOX proteins. Therefore, the viral lytic-latent balance is controlled by the relative abundance of counteracting host transcription factors that recruit different epigenetic regulators to the viral genome.

Indexed as

Epigenesis, GeneticForkhead Transcription FactorsHerpesvirus 1, HumanVirus LatencyAnimalsGene Expression Regulation, ViralGenome, ViralHerpes SimplexHumansMaleMiceNeuronsRepressor ProteinsSin3 Histone Deacetylase and Corepressor ComplexVirus ReplicationForkhead Transcription FactorsRepressor ProteinsSIN3A transcription factorSin3 Histone Deacetylase and Corepressor Complex

Identifiers

PMID41629328
PMCPMC12966480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.